Search by Drug Name or NDC

    NDC 00093-7870-65 Fentanyl Citrate 1600 ug/1 Details

    Fentanyl Citrate 1600 ug/1

    Fentanyl Citrate is a ORAL; TRANSMUCOSAL LOZENGE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is FENTANYL CITRATE.

    Product Information

    NDC 00093-7870
    Product ID 0093-7870_841d104f-e7c9-470f-9887-2533302348e4
    Associated GPIs 65100025108485
    GCN Sequence Number 041342
    GCN Sequence Number Description fentanyl citrate LOZENGE HD 1600 MCG BUCCAL
    HIC3 H3A
    HIC3 Description OPIOID ANALGESICS
    GCN 19194
    HICL Sequence Number 001747
    HICL Sequence Number Description FENTANYL CITRATE
    Brand/Generic Generic
    Proprietary Name Fentanyl Citrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fentanyl Citrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LOZENGE
    Route ORAL; TRANSMUCOSAL
    Active Ingredient Strength 1600
    Active Ingredient Units ug/1
    Substance Name FENTANYL CITRATE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Full Opioid Agonists [MoA], Opioid Agonist [EPC]
    DEA Schedule CII
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA020747
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-7870-65 (00093787065)

    NDC Package Code 0093-7870-65
    Billing NDC 00093787065
    Package 30 BLISTER PACK in 1 CARTON (0093-7870-65) / 1 LOZENGE in 1 BLISTER PACK (0093-7870-19)
    Marketing Start Date 2015-12-08
    NDC Exclude Flag N
    Pricing Information N/A